HIND
Price
$2.44
Change
+$0.37 (+17.87%)
Updated
Feb 4, 02:49 PM (EDT)
Capitalization
11.91M
Intraday BUY SELL Signals
YDES
Price
$11.00
Change
+$0.15 (+1.38%)
Updated
Feb 4, 03:21 PM (EDT)
Capitalization
766.57M
Intraday BUY SELL Signals
Interact to see
Advertisement

HIND vs YDES

Header iconHIND vs YDES Comparison
Open Charts HIND vs YDESBanner chart's image
Vyome Holdings
Price$2.44
Change+$0.37 (+17.87%)
Volume$4.08K
Capitalization11.91M
YD Bio
Price$11.00
Change+$0.15 (+1.38%)
Volume$261
Capitalization766.57M
HIND vs YDES Comparison Chart in %
HIND
Daily Signal:
Gain/Loss:
YDES
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HIND vs. YDES commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIND is a Hold and YDES is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (HIND: $2.07 vs. YDES: $10.85)
Brand notoriety: HIND and YDES are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HIND: 43% vs. YDES: 79%
Market capitalization -- HIND: $11.91M vs. YDES: $766.57M
HIND [@Biotechnology] is valued at $11.91M. YDES’s [@Biotechnology] market capitalization is $766.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HIND’s FA Score shows that 0 FA rating(s) are green whileYDES’s FA Score has 0 green FA rating(s).

  • HIND’s FA Score: 0 green, 5 red.
  • YDES’s FA Score: 0 green, 5 red.
According to our system of comparison, HIND is a better buy in the long-term than YDES.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HIND’s TA Score shows that 4 TA indicator(s) are bullish while YDES’s TA Score has 3 bullish TA indicator(s).

  • HIND’s TA Score: 4 bullish, 5 bearish.
  • YDES’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, HIND is a better buy in the short-term than YDES.

Price Growth

HIND (@Biotechnology) experienced а -36.50% price change this week, while YDES (@Biotechnology) price change was -10.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
YDES($767M) has a higher market cap than HIND($11.9M). YDES YTD gains are higher at: -10.993 vs. HIND (-39.826).
HINDYDESHIND / YDES
Capitalization11.9M767M2%
EBITDAN/AN/A-
Gain YTD-39.826-10.993362%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash5.71MN/A-
Total Debt38.6KN/A-
FUNDAMENTALS RATINGS
HIND: Fundamental Ratings
HIND
OUTLOOK RATING
1..100
95
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HINDYDES
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
19%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
16%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
17%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
21%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
21%
Advances
ODDS (%)
Bullish Trend 13 days ago
86%
Bullish Trend 8 days ago
25%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
25%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
41%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
32%
View a ticker or compare two or three
Interact to see
Advertisement
HIND
Daily Signal:
Gain/Loss:
YDES
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PTPPX17.410.06
+0.35%
Principal International Equity R5
CRARX10.380.03
+0.29%
NYLI CBRE Real Estate Class I
AIIYX21.85-0.08
-0.36%
Invesco EQV International Equity Y
AFGZX30.23-0.28
-0.92%
Alger Global Equity Z
MRIGX30.05-0.68
-2.21%
Meridian Growth Investor

HIND and

Correlation & Price change

A.I.dvisor tells us that HIND and CMPX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIND and CMPX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIND
1D Price
Change %
HIND100%
-5.91%
CMPX - HIND
21%
Poorly correlated
-1.53%
CRVS - HIND
21%
Poorly correlated
+1.72%
ACET - HIND
20%
Poorly correlated
-3.51%
EXOZ - HIND
6%
Poorly correlated
+5.53%
YDES - HIND
4%
Poorly correlated
-5.41%
More

YDES and

Correlation & Price change

A.I.dvisor tells us that YDES and OTLK have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YDES and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YDES
1D Price
Change %
YDES100%
-5.41%
OTLK - YDES
23%
Poorly correlated
-2.27%
CLDX - YDES
20%
Poorly correlated
+2.07%
HIND - YDES
4%
Poorly correlated
-5.91%
OSRH - YDES
3%
Poorly correlated
+2.49%
NGEN - YDES
3%
Poorly correlated
+0.96%
More